Abstract
Diabetes mellitus (DM) leads to the development of microvascular diseases and is associated with impaired angiogenesis. The presence of vascular endothelial growth factor (VEGF) can block PDGF-BB dependent regulation of neovascularization and vessel normalization. We tested the hypothesis that the inhibition of VEGF improves blood flow in a mouse hindlimb ischemia model produced by femoral artery ligation. In this study, we examined the effect of bevacizumab, a humanized monoclonal antibody against VEGF-A, on blood perfusion and angiogenesis after hindlimb ischemia. We showed that bevacizumab induces functional blood flow in high fat chow (HFC)-fed diabetic mice. Treatment with bevacizumab increased the expression of platelet derived growth factor-BB (PDGF-BB) in ischemic muscle, and led to vascular normalization. It also blocked vascular leakage by improving the recruitment of pericytes associated with nascent blood vessels, but it did not affect capillary formation. Furthermore, treatment with an anti-PDGF drug significantly inhibited blood flow perfusion in diabetic mice treated with bevacizumab. These results indicate that bevacizumab improves blood flow recovery through the induction of PDGF-BB in a diabetic mouse hindlimb...Continue Reading
References
Apr 29, 1993·Nature·K J KimN Ferrara
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·E BuchdungerN B Lydon
Jul 4, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kimmo MäkinenSeppo Ylä-Herttuala
Apr 2, 2003·Nature Medicine·Renhai CaoYihai Cao
Sep 25, 2003·Circulation·Sanjay RajagopalanBrian H Annex
Jan 8, 2005·Science·Rakesh K Jain
Jan 22, 2005·Current Opinion in Genetics & Development·Peter BalukDonald M McDonald
May 26, 2007·Investigative Ophthalmology & Visual Science·Felix BockClaus Cursiefen
Jul 3, 2007·Circulation Research·Ha Won KimTohru Fukai
Jul 26, 2008·Journal of the American College of Cardiology·Clarence M FindleyChristopher D Kontos
Jan 14, 2010·Cancer Research·Ker YuJames J Gibbons
May 27, 2010·Cancer Research·Maya H NisanciogluGuillem Genové
Mar 12, 2011·The Journal of Clinical Investigation·Kun-Wei LiuShi-Yuan Cheng
Jun 2, 2011·Nature Reviews. Drug Discovery·Peter Carmeliet, Rakesh K Jain
Mar 7, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrea BanfiHelen M Blau
May 19, 2012·PloS One·Rong LiJianbo Wu
Apr 6, 2013·Diabetes·Farah LizottePedro Geraldes
Jul 9, 2013·Nature Communications·Kayoko HosakaYihai Cao
Jan 28, 2015·Proceedings of the National Academy of Sciences of the United States of America·Meenal DattaRakesh K Jain
Jun 19, 2015·The Oncologist·Keith T FlahertyPeter J O'Dwyer
Citations
Jun 8, 2018·Medicinal Research Reviews·Yuanyuan ShanJie Zhang
Dec 6, 2018·American Journal of Physiology. Cell Physiology·Min ZengMao Luo
Jan 4, 2017·The Journal of Clinical Investigation·Clair CrewePhilipp E Scherer
May 3, 2018·Frontiers in Immunology·Daniel G SeddingJohann Bauersachs
Mar 16, 2021·Frontiers in Pharmacology·Yongjie LiJianbo Wu
Oct 19, 2021·Frontiers in Cell and Developmental Biology·Tendai HunyenyiwaAkiko Mammoto